Press release
Global Lupus Nephritis Market Expected to Achieve 7.5% CAGR by 2029: Growth Forecast Insights
Lupus Nephritis
How Large Will the Lupus Nephritis Market Size By 2025?
Significant expansion has characterized the lupus nephritis market over the immediately preceding years, with projections indicating a rise from its 2024 valuation of $1.94 billion to $2.08 billion by 2025, reflecting a compound annual growth rate (CAGR) of 7.4%. This upward momentum observed during the past period is attributable to multiple converging factors, including augmented financial commitments to lupus nephritis research, an escalating prevalence of various autoimmune conditions, increases in overall healthcare spending, the broader uptake of biologic therapies, alongside the enhanced utilization of remote healthcare consultations.
How Big Is the Lupus Nephritis Market Size Expected to Grow by 2029?
Anticipating substantial expansion, the lupus nephritis market is projected to achieve a valuation of $2.78 billion by 2029, exhibiting a robust compound annual growth rate (CAGR) of 7.5% throughout the forecast duration. This upward trajectory is primarily fueled by escalating physician consciousness regarding the condition, a greater uptake of biologic treatments, the proliferation of specialized medical centers, heightened recognition of renal transplantation's significance, and broader availability of nephrology care. Key developments shaping this market moving forward encompass innovations within biologic therapeutics, the integration of tailored medical strategies, the discovery of new biomarkers for diagnosis, the scaling up of ongoing clinical investigations, and progress in the realm of stem cell applications.
View the full report here:
https://www.thebusinessresearchcompany.com/report/lupus-nephritis-global-market-report
Which Key Market Drivers Powering Lupus Nephritis Market Expansion and Growth?
Anticipated expansion in the lupus nephritis sector is largely attributable to the rising incidence of genetic susceptibility, a state where an individual's inherited makeup elevates their risk for specific ailments. This heightened prevalence of genetic factors stems from a combination of hereditary transmission, interaction with external surroundings, and alterations within particular genes. The growing count of cases linked to inherited traits significantly influences lupus nephritis evolution, underlining the substantial effect genetic inheritance has on autoimmune conditions, especially those involving renal impairment. To illustrate this dynamic, data from the UK CF Registry, reported by the Cystic Fibrosis Trust in October 2024, showed that the number of registered patients with cystic fibrosis climbed from 11,148 in 2022 to 11,318 in 2024, marking a 1.52 percent rise in afflicted individuals; consequently, this escalating presence of underlying genetic risk factors fuels the market expansion for lupus nephritis treatments.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22044&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Lupus Nephritis Market?
Leading corporations within the lupus nephritis arena are concentrating their efforts on innovating superior, second-generation calcineurin inhibitors with the goal of boosting therapeutic effectiveness and securing better enduring renal results for those afflicted. These newer calcineurin inhibitors serve to quell the inflammatory processes characteristic of lupus nephritis and safeguard kidney function through the careful regulation of the body's immune reactions. Furthermore, in September of 2024, the Canadian biopharmaceutical firm Aurinia Pharmaceuticals Inc. disclosed that Japan's Ministry of Health, Labour, and Welfare granted authorization for LUPKYNIS (voclosporin) to be administered in treating this condition. This regulatory clearance permits the use of voclosporin alongside mycophenolate mofetil (MMF), supported by evidence gathered throughout the AURORA Clinical Program that confirmed its safety profile and positive results. This specific authorization represents a considerable step forward in broadening the available therapeutic pathways for patients battling lupus nephritis across Japan, thereby fostering improved control over the illness and its ultimate prognosis.
What Are the Emerging Segments in the Lupus Nephritis Market?
The lupus nephritismarket covered in this report is segmented -
1) By Stage: Class 1; Class 2; Class 3; Other Stages
2) By Drug Class: Immunosuppressive Drugs; Corticosteroids; Biological Agents; Antimalarial Drugs
3) Route Of Administration: Oral; Parenteral; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
5) By End-User: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Class 1: Asymptomatic Cases; Mild Proteinuria; Incidental Diagnosis.
2) By Class 2: Mild Hematuria; Low-Grade Proteinuria; Minimal Immune Complex Deposition.
3) By Class 3: Active Lesions; Chronic Sclerotic Lesions; Crescent Formation.
4) By Other Stages: Class 4 (Diffuse Lupus Nephritis); Class 5 (Membranous Lupus Nephritis); Class 6 (Advanced Sclerotic Lupus Nephritis)
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=22044&type=smp
Who Are the Global Leaders in the Lupus Nephritis Market?
Major companies operating in the lupus nephritis market are F. Hoffmann-La Roche Ltd., Bristol Myers Squibb, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Genentech, Astrazeneca PLC, Biocon Biologics, Hanmi Pharmaceutical Co. Ltd., Sana Biotechnology Inc., RemeGen Co. Ltd., Aurinia Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Equillium Inc., Anthera Pharmaceuticals Inc., Atara Biotherapeutics Inc., Artiva Biotherapeutics, Caribou Biosciences, Nkarta Inc., Adicet Bio Inc., Lupus Research Alliance, Kyverna Therapeutics Inc., Kezar Life Sciences, Bionxt Solutions.
Which are the Top Profitable Regional Markets for the Lupus Nephritis Industry?
Asia-Pacific was the largest region in the lupus nephritis market in 2024. The regions covered in the lupus nephritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22044
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Lupus Nephritis Market Expected to Achieve 7.5% CAGR by 2029: Growth Forecast Insights here
News-ID: 4281746 • Views: …
More Releases from The Business Research Company
Smart Pill Dispenser Market Analysis Highlights Growth To $5.54 Billion By 2030 …
The smart pill dispenser market is gaining significant momentum with promising growth prospects expected over the coming years. This expanding sector is being shaped by technological advancements and increasing demand for efficient medication management solutions, particularly as healthcare delivery continues to evolve toward remote and connected care models. Let's explore the market's projected growth, key players, emerging trends, and detailed segmentation.
Forecasted Growth and Market Value of the Smart Pill Dispenser…
Smart Orthopedic Implants Market Report 2026 Market Outlook Supported By A Forec …
The smart orthopedic implants market is set to experience substantial growth as technological advancements and demographic shifts drive demand. Innovations in sensor technology and artificial intelligence are transforming orthopedic care, offering more personalized and effective treatment options. This evolving sector is attracting significant attention from both established players and new entrants aiming to capitalize on emerging opportunities.
Projected Growth Trajectory for the Smart Orthopedic Implants Market Through 2030
The smart…
Smart Mattress Overlay (Hospital) Market Outlook Highlights Strategic Opportunit …
The smart mattress overlay (hospital) market is set to undergo significant expansion in the coming years, driven by advancements in healthcare technology and increasing demand for improved patient care solutions. This market is poised to transform hospital infrastructure and patient management by integrating intelligent systems designed for enhanced monitoring and comfort. Let's explore the market's size, key players, trends, and segmentation to understand its future trajectory.
Market Size Outlook and Growth…
Smart Infusion Pumps Market Research Reveals Strong 9.2% CAGR Outlook Through 20 …
The smart infusion pumps market is on the brink of significant expansion driven by ongoing technological advancements and growing healthcare demands. As healthcare providers seek safer and more efficient drug delivery solutions, smart infusion pumps are becoming increasingly vital. Let's explore the market size, key players, emerging trends, and major segments shaping this industry's future.
Projected Growth and Market Size of the Smart Infusion Pumps Market
The smart infusion pumps…
More Releases for Lupus
Lupus Nephritis Clinical Trial Pipeline Analysis: 25+ Key Companies Shaping the …
DelveInsight's Lupus Nephritis Pipeline Insight 2026 report provides comprehensive global coverage of available, marketed, and pipeline Lupus Nephritis therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Lupus Nephritis pipeline domain.
Key takeaways from the Lupus Nephritis Clinical Trial Landscape Report
• DelveInsight's Lupus Nephritis pipeline report depicts a robust space with 25+ active players working to develop 40+…
Cutaneous Lupus Erythematosus (CLE) Market
Introduction
Cutaneous Lupus Erythematosus (CLE) is a chronic autoimmune skin disorder, often associated with systemic lupus erythematosus (SLE), that presents as inflammation, rashes, and photosensitivity. While CLE is rarely fatal, it significantly affects patients' physical and emotional well-being, often leading to scarring, disfigurement, and social stigma.
Over the past decade, the market for CLE therapies has gained global importance as research into autoimmunity has accelerated and biologic therapies have transformed dermatology. Rising…
Cutaneous Lupus Erythematosus (CLE) Market
Market Overview:
The Global Cutaneous Lupus Erythematosus (CLE) Market is forecasted to achieve a High CAGR during the period 2023-2030. CLE encompasses a spectrum of dermatological symptoms that may precede or accompany systemic lupus erythematosus (SLE), an autoimmune condition impacting multiple organs. Timely diagnosis and treatment of CLE can prevent the onset of severe systemic symptoms.
Market Dynamics:
Drivers:
Rise in Clinical Studies: Technological advancements leading to faster and accurate diagnosis have spurred additional…
Lupus Nephritis Treatment Market 2030
Global Lupus Nephritis Treatment market is expected to be worth roughly USD 8,048 million by 2030, growing at a CAGR of 7.3% during the forthcoming period of 2022-2030, according to Ameco Research
Lupus nephritis is one of the most rapidly spreading diseases over the globe. The increasing frequency of lupus nephritis and consumer awareness has fuelled the worldwide lupus nephritis treatment market. Another crucial factor driving the pace of growth of…
Lupus Erythematosus Market -API Insights, 2017
Summary
Orbis Research Present “Lupus Erythematosus-API Insights, 2017”
Description
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage…
Global Systemic Lupus Erythematosus and Lupus Nephritis Market to Display 10.6% …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz has announced the addition of a new report, titled “PharmaPoint: Systemic Lupus Erythematosus And Lupus Nephritis - Global Drug Forecast And Market Analysis To 2025,” to its expanding repository of research reports. The market…
